Navigation Links
PharmSource Lead Sheet Adds Coverage of Medical Devices and Diagnostics
Date:12/12/2012

Fairfax, VA (PRWEB) December 11, 2012

PharmSource Information Services, Inc. (PharmSource) has announced that it now offers a concise data-driven resource that delivers targeted business opportunities to companies supporting the medical device/diagnostic arena, worldwide.

This offering, known as the PharmSource Lead Sheet: Devices & Diagnostics Edition, provides pipeline updates regarding medical device and diagnostic candidates in the clinical trial process, as well as approvals and clearances in the US and abroad. Weekly updates signal when medical devices or diagnostics move into a new development stage. Product coverage includes pre-feasibility through post-marketing, acquisitions and alliances. In addition, users are informed company acquisitions and alliances, corporate-level financings and other deals and events that signal corporate expansions or contractions.

The availability of a weekly supply of fresh intelligence on the medical device and diagnostic world in this single-source, user-friendly resource is expected to be a major boon for CROs, CMOs and other companies providing services in this industry.

This resource enables service providers to easily identify new opportunities based on criteria that are relevant to specific needs (i.e., therapeutic specialty; device/diagnostic purpose or type; approval status; class; lifespan; invasiveness; material; and more). Hotlinks go immediately to deeper information about both the product and the company. In addition, verified contacts are provided for each company reported in the weekly report to help business development teams start calls at the right level.

For a limited time, PharmSource is offering a complimentary walk-through of the PharmSource Lead Sheet: Devices & Diagnostics Edition for qualified companies. For more information, contact PharmSource directly at 1-703-383-4903, ext. 112 / info(at)pharmsource(dot)com.

About PharmSource®
PharmSource specializes in bringing together buyers and sellers of contract services related to drug development and manufacturing. Founded in 1996, this globally respected provider of proprietary databases and insightful market intelligence serves clients’ strategic information needs and helps them to be aware of and fully understand critical sourcing factors and make optimal operating and strategic decisions. To learn more, visit PharmSource at http://www.pharmsource.com, or contact info(at)pharmsource(dot)com / phone: 1-703-383-4903 (USA, eastern time-zone).

Read the full story at http://www.prweb.com/releases/PharmSource/Dec2012/prweb10194466.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Northwest Bio Implements Major Balance Sheet Clean-Up
2. UMass Amherst polymer scientists, physicists develop new way to shape thin gel sheets
3. Simple, cheap way to mass-produce graphene nanosheets
4. Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis
5. Research Alert -- Empire Asset Management Co. Initiates Coverage on Exact Sciences (NASDAQ: EXAS)
6. A New Dawn in Cosmetics Coverage: Cosmetics Design Launches Asia-Pacific News Website
7. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
8. DiaTech Life Sciences Announces Medical Advisory Board
9. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
10. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
11. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... DENVER, COLORADO (PRWEB) , ... December 05, 2016 ... ... podcast series hosted by one of the nation’s premier cannabis technology and application ... the founder and CEO of Cultivate Colorado. Over the past 30 years, Chip ...
(Date:12/5/2016)... , Dec. 5, 2016  Renova™ Therapeutics, a ... heart failure and other chronic diseases, announced that ... company as Chief Financial Officer (CFO), effective today. ... 20 years of experience in financial management for ... and software companies. Most recently, Ms. Bovenizer was ...
(Date:12/5/2016)... LAKE, N.J. , Dec. 5, 2016 /PRNewswire/ ... Phase 3 open-label two-year study of rufinamide, which ... the American Epilepsy Society (AES) held from December ... Analysis of final two-year safety, tolerability and cognitive ... with rufinamide experienced similar safety and tolerability profiles, ...
(Date:12/4/2016)... ... December 02, 2016 , ... A proposed five-year ... in federally funded research and development is welcome news for the photonics community, ... . , As part of the National Defense Authorization Act (NDAA) compromise agreement ...
Breaking Biology Technology:
(Date:11/15/2016)... Research and Markets has announced the addition of the ... their offering. ... The global bioinformatics market ... 6.21 Billion in 2016, growing at a CAGR of 21.1% during ... is driven by the growing demand for nucleic acid and protein ...
(Date:11/14/2016)... Nov. 14, 2016  Based on its ... Frost & Sullivan recognizes FST Biometrics with ... for Visionary Innovation Leadership. FST Biometrics emerged ... identification market by pioneering In Motion Identification ... instant, seamless, and non-invasive verification. This patented ...
(Date:6/22/2016)... , June 22, 2016  The American College of Medical ... Show Executive Magazine as one of the fastest-growing trade ... 25-27 at the Bellagio in Las Vegas ... highest percentage of growth in each of the following categories: ... companies and number of attendees. The 2015 ACMG Annual Meeting ...
Breaking Biology News(10 mins):